Tag: Organizations

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly Role of international organizations in promoting POCT

    Neftaly Role of international organizations in promoting POCT

    Role of International Organizations in Promoting Point-of-Care Testing (POCT)

    Point-of-Care Testing (POCT) has become a critical tool in global health, enabling rapid, decentralized diagnostics that strengthen health systems, especially in low-resource settings. While the technology behind POCT is innovative, its widespread adoption and effective use have been significantly supported by the efforts of international organizations. These organizations play a key role in advancing access, policy, funding, training, and standardization of POCT worldwide.


    Key Roles of International Organizations in POCT Promotion

    1. Policy Development and Global Guidelines

    International organizations such as the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) provide authoritative guidelines that help countries integrate POCT into national health strategies.

    • WHO develops technical standards and essential diagnostics lists, helping countries identify and prioritize POCT technologies.
    • Guidelines ensure that POCT is used safely, ethically, and effectively in various settings.

    2. Funding and Resource Mobilization

    Agencies like the Global Fund to Fight AIDS, Tuberculosis and Malaria, GAVI, and the World Bank provide financial support to scale up POCT access in low- and middle-income countries.

    • Funding covers procurement, training, supply chain development, and integration into health systems.
    • Public-private partnerships initiated by these organizations support sustainable access to diagnostics.

    3. Capacity Building and Training

    International bodies organize training programs to ensure healthcare workers can use POCT correctly and interpret results effectively.

    • WHO and Médecins Sans Frontières (Doctors Without Borders) offer toolkits and field guides.
    • Capacity building ensures quality and reliability in POCT deployment, even in emergency contexts.

    4. Quality Assurance and Standardization

    Organizations like ISO (International Organization for Standardization) and Clinton Health Access Initiative (CHAI) help countries establish quality assurance frameworks for POCT.

    • Standardization ensures consistent test performance and patient safety.
    • Support includes guidance on regulatory approvals and supply chain management.

    5. Emergency Response and Epidemic Control

    During global health emergencies such as the COVID-19 pandemic or Ebola outbreaks, international organizations:

    • Deploy POCT kits to frontline settings.
    • Coordinate emergency logistics and training.
    • Share data to enhance global surveillance and response strategies.

    6. Advocacy and Awareness

    International organizations raise global awareness about the benefits and importance of POCT in achieving universal health coverage (UHC) and the Sustainable Development Goals (SDGs).

    • Campaigns and reports influence national governments, donors, and the private sector to invest in diagnostic innovation.
    • They promote equity in access to life-saving diagnostics.

    Conclusion

    International organizations are instrumental in advancing the adoption, quality, and impact of POCT around the world. Through policy guidance, funding, training, and advocacy, they ensure that POCT reaches the communities where it is needed most, transforming the way healthcare is delivered—particularly in resource-limited and emergency settings.

  • Neftaly Role of international organizations in influencing biomarker policy

    Neftaly Role of international organizations in influencing biomarker policy

    Role of International Organizations in Influencing Biomarker Policy

    Biomarkers have emerged as critical tools in advancing precision medicine, early diagnosis, and improved patient outcomes globally. The development and implementation of effective biomarker policies, however, require coordination, guidance, and support that transcend national boundaries. This is where international organizations play a pivotal role.

    At Neftaly, we recognize that international organizations are instrumental in shaping biomarker policies by providing technical expertise, fostering collaboration, and promoting standards that ensure equitable access and ethical use.


    Key Contributions of International Organizations

    1. Setting Global Standards and Guidelines

    • Organizations like the World Health Organization (WHO) and the International Council for Harmonisation (ICH) develop evidence-based guidelines for biomarker validation, clinical use, and regulatory approval.
    • These standards promote consistency and quality assurance, enabling countries to align their policies with international best practices.

    2. Providing Technical Assistance and Capacity Building

    • International bodies offer training, resources, and technical support to strengthen national capacities in biomarker research, regulation, and implementation.
    • Programs facilitated by organizations such as the Global Fund, Gavi, and UNICEF often include components that support biomarker integration into disease control strategies.

    3. Facilitating Research Collaboration and Data Sharing

    • Platforms coordinated by entities like the Coalition for Epidemic Preparedness Innovations (CEPI) and the Global Alliance for Genomics and Health (GA4GH) foster global collaboration on biomarker research.
    • Sharing data and best practices accelerates innovation and informs policy development based on diverse populations and contexts.

    4. Advocating for Equity and Access

    • International organizations emphasize reducing health disparities by advocating for the inclusion of biomarker technologies in essential diagnostics lists and universal health coverage schemes.
    • They work to ensure marginalized and low-resource settings benefit from biomarker advancements.

    5. Mobilizing Funding and Resources

    • Many international organizations manage or influence global financing mechanisms that support biomarker research, validation, and deployment.
    • Their advocacy efforts help channel investments toward sustainable biomarker policies and health system integration.

    Challenges and Opportunities

    • Challenges: Variability in national regulatory frameworks, limited infrastructure in low-income settings, and ethical considerations around data privacy.
    • Opportunities: Strengthening global partnerships, harmonizing regulatory pathways, and leveraging digital health innovations to scale biomarker use.

    Conclusion

    International organizations play a crucial role in shaping biomarker policy by providing the frameworks, knowledge, and resources needed to translate scientific advances into health gains worldwide. Neftaly supports leveraging these global partnerships to promote biomarker policies that are effective, equitable, and sustainable.